Isthmus Pharmaceuticals Private Limited, a active private limited company, was established on 01 November 2013 in Delhi, Delhi, India. Engaging in other wholesale within the trading sector, it holds CIN: U51909DL2013PTC259766. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a active non-compliant status. Its leadership includes Shiv Prakash Dwivedi (Director), Kulbhushan Rana (Additional Director), Kavita (Director). Past directors included Shiv Prakash Dwivedi, Kulbhushan Rana, Prashant Chauhan. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at B - 73 & 74, First Floor, Flat No. 02 G. D. Colony, Mayur Vihar Pahse Iii, Delhi, Delhi, 110096.
U51909DL2013PTC259766
259766
01 November 2013
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Isthmus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Prakash Dwivedi | Director | 25 Jul 2016 | Current |
| Kulbhushan Rana | Additional Director | 15 Dec 2016 | Current |
| Kavita | Director | 10 Aug 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 06 Jan 2018 | Past |
| Pramod Abcsdd | Director | 25 Jul 2016 | Past |
| Pramod Abcsdd | Director | 10 Aug 2016 | Past |
| Pramod Abcsdd | Director | 20 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Isthmus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Isthmus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2015 | Punjab National Bank | ₹4.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Isthmus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Isthmus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isthmus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kulbhushan Rana was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
The activity Isthmus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was completed.
Progress on Kavita was appointed as a Director was appointed as a Director on 10 Aug 2016 & has been associated with this company since 9 years 3 months . was documented.
Shiv Prakash Dwivedi was appointed as a Director was appointed as a Director on 25 Jul 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
The activity Isthmus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was completed.
A charge with Punjab National Bank amounted to Rs. 4.50 M with Charge ID 10589444 was registered on 12 Aug 2015. was recorded as a recent event.
The CIN of Isthmus Pharmaceuticals Private Limited is U51909DL2013PTC259766.
Isthmus Pharmaceuticals Private Limited is headquartered at B - 73 & 74, First Floor, Flat No. 02 G. D. Colony, Mayur Vihar Pahse Iii, Delhi, Delhi, 110096.
Isthmus Pharmaceuticals Private Limited was incorporated on 01 November 2013.
The current directors of Isthmus Pharmaceuticals Private Limited are
The primary industry of Isthmus Pharmaceuticals Private Limited is Trading.
Isthmus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Isthmus Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Isthmus Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX